The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Alzheimer's Disease
Interventions
DRUG

Donepezil

5 mg capsule, orally, once daily, first 14 days of treatment

DRUG

Donepezil

10 mg, orally, once daily, for remaining 70 days of treatment

DRUG

Placebo to match Aricept

Placebo capsule, orally, 84 days of treatment

Trial Locations (18)

Unknown

Research Site, Ottawa

Research Site, Gatineau

Research Site, Montreal

Research Site, Québec

Reearch Site, Québec

Research Site, Callao

Research Site, Callao

Research Site, Lima

Research Site, Chojnice

Research Site, Gdansk

Research Site, Kalisz

Research Site, Piła

Research Site, Poznan

Research Site, Sopot

Research Site, Ścinawa

Research Site, Warsaw

Research Site, Cape Town

Research Site, Roodepoort

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY